Our Blog – What moves us

ip2 sponsoring Jethro Tull

ip2 sponsoring Jethro Tull

15 years of open-air festival at the Castle of Rheydt After a one-year absence caused by the pandemic, the Summer Music at Rheydt Castle could take place for the 15th time this year. Until one day before the start on August 19 - the stage and lighting system were...

mehr lesen
Sunrise for the unified patent court

Sunrise for the unified patent court

As explained in general in our earlier post, dated December 06, 2020, it looks like the Unified patent court is close to come – probably by the End of 2022. Three months before the entry into force of the agreement – the so-called „sunrise period“ – it will be...

mehr lesen
Sound marks: much ado about something

Sound marks: much ado about something

The purpose of trademarks is to distinguish the goods and services of one company from those of another. Whether a sign can be registered as a trademark therefore depends to a large extent on whether the relevant public can recognize an indication of origin in it. ...

mehr lesen
Again: Bunnies in for a rough ride

Again: Bunnies in for a rough ride

Another bad day for bunnies. This time it was the purple milk bunny and for a change it was not about the infringement of trademark rights, but about a violation of the labeling obligation for food, which the judges at the Bremen Regional Court had to decide on (12 O...

mehr lesen
There can be only one … gold chocolate bunny

There can be only one … gold chocolate bunny

With more than 500 million sold over the past three decades and a market share of over 40 percent (2017), the chocolate bunny in gold foil, red bow and bell is the clear market leader. But there can be no talk of post-Easter peace. Bad karma for gold bunnies in the...

mehr lesen
COVID variants and vaccination: A race against time

COVID variants and vaccination: A race against time

The COVID-19 pandemic has reached its first-year anniversary in recent days. With sad milestones such as almost 3 million deaths and far over 100 million reported infections, we are just starting to process the dire consequences this disease has not only on our...

mehr lesen
Intel becomes victim of patent trolls

Intel becomes victim of patent trolls

Dubious business model Patent trolls are well-funded companies that have no research and development of their own and whose business model is to buy up patents at low prices and then try to enforce them against alleged (or actual) infringers. Last year, for example,...

mehr lesen
Molnupiravir: The next cure for Cov-2?

Molnupiravir: The next cure for Cov-2?

Molnupiravir (development codes MK-4482 and EIDD-2801) is an experimental antiviral drug originally developed by Emory University for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine and exerts its antiviral effect...

mehr lesen
Smart cars for ECJ

Smart cars for ECJ

The patent dispute between Nokia and Daimler concerning alleged infringement of various mobile communications patents will now step to the ECJ. On Thursday December 17, 2020 the Düsseldorf Regional Court (LG) announced submitting several questions to the ECJ...

mehr lesen
Union trademarks in the UK after Brexit

Union trademarks in the UK after Brexit

The Brexit becomes effective At the end of the year, the transitional period expires and the Brexit becomes effective. Recently, the rules for the extension of Union trademarks to the UK have been clarified: 1. All Union trademarks.. registered or to be registered by...

mehr lesen
mRNA Corona vaccines: A step towards normality

mRNA Corona vaccines: A step towards normality

The second Corona wave As the second Corona wave is accelerating in Europe and the US, thereby forcing us again to restrict our social interaction to a bare minimum, the announcements in recent days by Pfizer/BioNTech and Moderna of highly effective vaccines...

mehr lesen

Our Authors

Bernd Fabry is founder and CEO of IP2. He is a qualified German and European Patent and Trademark Attorney. He has more than 25 years company experience as Head of IP departments. 

Dr. Bernd Fabry - CEO

We are pleased that our Scientific Adviser, Dr. Martin Fabry from the University of Cambridge, will now report regularly on new developments in this exciting field.

Dr. Martin Fabry - Scientific Advisor

Subscribe to our newsletter!

Never miss the newest blog post or important information about patents and laws